Temelimab versus placebo in patients with post-COVID condition
Mayssam Nehme, Margret Hund‐Georgiadis, Esther del Corral Beamonte, Pierre‐Olivier Bridevaux et autres
0 citationsBrain Behavior and Immunity
Anke Post
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
45Publications signalées
2701Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Parkinson's Disease Mechanisms and TreatmentsTranscranial Magnetic Stimulation StudiesNeurological disorders and treatmentsTreatment of Major DepressionFunctional Brain Connectivity Studies
Publications récentes
Temelimab versus placebo in patients with post-COVID condition.
M. Nehme, Margret Hund‐Georgiadis, Esther Del Corral Beamonte, Pierre‐Olivier Bridevaux et autres
0 citationsOpen Access CRIS of the University of Bern
Quantitative Systems Pharmacology Models of Anti‐Amyloid Treatments for Alzheimer’s Disease: A Systematic Review
Lara Herriott, Mark Coles, Eamonn A. Gaffney, Nicolas Fournier et autres
0 citationsAlzheimer s & Dementia
Author Correction: Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trials
Gennaro Pagano, Dylan Trundell, Tanya Simuni, Nicola Pavese et autres
0 citationsnpj Parkinson s Disease
Exploratory digital outcome measures of motor sign progression in Parkinson’s disease patients treated with prasinezumab
Kirsten I. Taylor, Florian Lipsmeier, Marzia A. Scelsi, Ekaterina Volkova-Volkmar et autres
14 citationsnpj Digital Medicine
[Liothyronine augmentation in depression].
0 citationsPubMed
Use of experimental medicine approaches for the development of novel psychiatric treatments based on orexin receptor modulation
Amy Beckenstrom, Preciosa M. Coloma, Gerard R. Dawson, Ailidh K. Finlayson et autres
7 citationsNeuroscience & Biobehavioral Reviews
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort
Tanya Simuni, Kalpana Merchant, Michael C. Brumm, Hyunkeun Cho et autres
19 citationsnpj Parkinson s Disease
Accuracy in recognising happy facial expressions is associated with antidepressant response to a NOP receptor antagonist but not placebo treatment
Gerard R. Dawson, Anke Post, Trevor Smart, Michael Browning et autres
15 citationsJournal of Psychopharmacology
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data
Gennaro Pagano, Frank Boess, Kirsten I. Taylor, Benedicte Ricci et autres
89 citationsFrontiers in Neurology
A Phase II study to evaluate the safety and efficacy of prasinezumab in early Parkinson’s disease (PASADENA): rationale, design and baseline data
Gennaro Pagano, Frank Boess, Kirsten I. Taylor, Benedicte Ricci et autres
8 citationsmedRxiv
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
Tanya Simuni, Liz Uribe, Hyunkeun Ryan Cho, Chelsea Caspell-Garcia et autres
141 citationsThe Lancet Neurology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.